Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.04
+0.12 (0.93%)
Aug 15, 2025, 10:46 AM - Market open

Adaptive Biotechnologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
43.1647.9265.0690.03139.07123.44
Upgrade
Short-Term Investments
154.71174.37281.34408.17214564.83
Upgrade
Cash & Short-Term Investments
197.87222.29346.4498.2353.06688.27
Upgrade
Cash Growth
-32.21%-35.83%-30.47%41.11%-48.70%19.31%
Upgrade
Accounts Receivable
44.2941.7337.9740.0617.4110.05
Upgrade
Other Receivables
1.31.310.81.42.5
Upgrade
Receivables
45.5943.0338.9740.8618.8112.55
Upgrade
Inventory
8.48.4414.4514.4519.2614.06
Upgrade
Prepaid Expenses
109.9910.378.6411.6212.04
Upgrade
Total Current Assets
261.86283.75410.19562.15402.75726.91
Upgrade
Property, Plant & Equipment
84.3994.38120.32164.21172.94139.04
Upgrade
Long-Term Investments
24.133.66--217.15118.53
Upgrade
Goodwill
118.97118.97118.97118.97118.97118.97
Upgrade
Other Intangible Assets
2.583.435.136.838.5310.23
Upgrade
Other Long-Term Assets
4.735.186.524.463.012.74
Upgrade
Total Assets
496.64539.38661.13856.62923.341,116
Upgrade
Accounts Payable
6.917.277.728.083.313.24
Upgrade
Accrued Expenses
16.9120.6720.3924.122.218.92
Upgrade
Current Portion of Long-Term Debt
3.070.87----
Upgrade
Current Portion of Leases
9.9610.249.389.235.063.53
Upgrade
Current Income Taxes Payable
-0.180.060.190.390.37
Upgrade
Current Unearned Revenue
55.355.6948.6364.1280.4673.32
Upgrade
Other Current Liabilities
-3.151.844.072.395.82
Upgrade
Total Current Liabilities
92.1498.0588.02109.79113.81105.2
Upgrade
Long-Term Debt
130.5132.41130.66125.36--
Upgrade
Long-Term Leases
74.4179.1589.3998.77106.69104.33
Upgrade
Long-Term Unearned Revenue
20.0327.2644.7958.698.75163.62
Upgrade
Other Long-Term Liabilities
0.020.02----
Upgrade
Total Liabilities
317.1336.89352.86392.52319.24373.15
Upgrade
Common Stock
0.020.010.010.010.010.01
Upgrade
Additional Paid-In Capital
1,5391,5061,4531,3871,3241,254
Upgrade
Retained Earnings
-1,359-1,304-1,144-919.08-718.89-511.61
Upgrade
Comprehensive Income & Other
0.070.170.22-4.12-1.140.89
Upgrade
Total Common Equity
179.72202.71308.4464.17603.99743.27
Upgrade
Minority Interest
-0.18-0.22-0.12-0.070.11-
Upgrade
Shareholders' Equity
179.54202.49308.28464.1604.1743.27
Upgrade
Total Liabilities & Equity
496.64539.38661.13856.62923.341,116
Upgrade
Total Debt
217.94222.67229.43233.36111.74107.86
Upgrade
Net Cash (Debt)
4.0433.29116.97264.83458.47698.93
Upgrade
Net Cash Growth
-93.85%-71.54%-55.83%-42.23%-34.41%8.24%
Upgrade
Net Cash Per Share
0.030.230.811.863.275.33
Upgrade
Filing Date Shares Outstanding
152.27148.58145.09143.23141.58139.22
Upgrade
Total Common Shares Outstanding
152.23147.77145.08143.11141.39137.65
Upgrade
Working Capital
169.72185.7322.17452.36288.94621.72
Upgrade
Book Value Per Share
1.181.372.133.244.275.40
Upgrade
Tangible Book Value
58.1680.31184.3338.37476.49614.07
Upgrade
Tangible Book Value Per Share
0.380.541.272.363.374.46
Upgrade
Machinery
-59.3361.3656.748.8834.08
Upgrade
Construction In Progress
-2.573.417.635.667.19
Upgrade
Leasehold Improvements
-73.2874.7372.465.9621.95
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q